Bs for MPS Laboratory Test: Procedure and Results

Among the array of malaria diagnostic methods, BS for MPS ( Blood Smear for Malaria Parasite) stands out as a fundamental and widely used laboratory test. Other informal terms for the test include MPS for malaria and blood slide for malaria parasite.

Malaria, a disease transmitted through the bite of infected mosquitoes, continues to cast a long shadow over global public health. Despite ongoing efforts to control its spread, malaria remains a significant cause of morbidity and mortality, particularly in tropical and subtropical regions. One of the critical pillars in the battle against malaria lies in accurate and timely diagnosis, setting the stage for effective treatment and preventing complications.

Background on Malaria

Malaria is a mosquito-borne illness caused by parasitic protozoans of the genus Plasmodium. This ancient malady has plagued humanity for centuries, leaving an indelible mark on communities across the globe, particularly in tropical and subtropical regions.

Malaria is primarily transmitted to humans from the bite of an infected female Anopheles mosquitoes. The parasites responsible for the disease belong to the Plasmodium genus, with Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi being the five species that commonly infect humans. The female mosquitoes act as carriers, transferring the parasites into the bloodstream during a blood meal, initiating the complex life cycle of the Plasmodium parasite within the human host.

Purpose and Significance of BS for MPS

BS for MPS plays a pivotal role in unraveling the microscopic complexities of Malaria. Its significance lies not only in its ability to confirm the presence of malaria parasites but also in providing valuable insights into the species, stages of development, and, to some extent, the severity of the infection.

The uniqueness of BS for MPS lies in its ability to visualize the malaria parasites directly under a microscope. Unlike some rapid malaria antigen tests (MRDT) or molecular methods that identify the parasite’s genetic material, the blood smear offers a real-time glimpse into the actual presence and morphology of Plasmodium parasites within the patient’s blood. This direct visualization allows for a more nuanced understanding of the infection.

BS for MPS goes beyond merely confirming the presence of parasites; it enables the identification of the specific species responsible for the infection. This information is invaluable in tailoring treatment regimens, as some species may resist certain antimalarial drugs.

BS for MPS excels in capturing this dynamic process, allowing healthcare professionals to assess the stage of the infection. This staging is critical not only for understanding the progression of the disease but also for estimating the parasite density, a factor linked to the severity of the infection.

Preparation for MPS for malaria test

BS for MPS procedure is a meticulous and standardized process that involves several key steps, each contributing to the accuracy and reliability of the diagnostic results. 

1. Patient Preparation and Consent

Establishing a foundation of trust and cooperation with the patient is imperative. A clear and thorough explanation of the procedure is provided, ensuring the patient understands the importance of the test. Informed consent is obtained, adhering to ethical standards and respecting the patient’s autonomy.

2. Blood Collection

The next step involves the collection of a blood sample. Depending on the healthcare facility’s protocols and patient conditions, this process can be executed through a traditional vein puncture or a less invasive fingerstick. Vein puncture is performed using a sterile needle and syringe, while fingerstick methods involve pricking the fingertip with a lancet to obtain a small blood sample.

BS for MPS test procedure

1. Prepare Thin and Thick Blood Smears by placing a small drop of blood near one end of a clean glass slide for the thin smear. For the thick smear, place a larger drop of blood and spread it more densely to enhance parasite visibility.

2. Fix the thin smear by gently passing the slide through a methanol vapor for approximately 1-2 seconds.

3. Allow the smear to air-dry completely to ensure proper fixation.

4. Submerge the fixed thin smear in 10% Giemsa stain for 10-15 minutes.

5. Rinse the slide gently with distilled water to remove excess stain.

6. Allow the slide to air-dry.

7. Examine the stained blood smear under a microscope using the oil immersion lens.

BS for MPS Results Interpretation

Here’s a step-by-step guide on accurately and effectively reporting BS for MPS results using light microscopy.

1. Ensure you have stained slides with specimens, a lab register, and patient result forms. These are the fundamental tools for the reporting process.

2. Examine the stained slides under a light microscope.

3. Count and record all malaria species and stages observed, capturing the intricate details of the microscopic landscape.

4. Determine the number of white blood cells (WBC) relative to parasites, setting the foundation for subsequent calculations.

5. Calculate White Blood Cell and Parasitic Counts:

If an exact count isn’t feasible, calculate the patient’s white blood cell count (WBC/uL), employing an estimated 8000 cells/uL.

Use the formula: (No. of asexual parasites * WBC count) / No. Of white cells relative to parasites to calculate the parasitic count (parasites/uL of blood).

6. Report each species and stage individually, providing a comprehensive overview of the infection. Use a clear and standardized format, mentioning the type of parasite, the stage observed, and the calculated parasitic count.

Examples in Reporting:

For Plasmodium falciparum trophozoites, state the count, WBC relative to parasites, estimated WBC count, and parasitic count.

In mixed infections, count all species (sexual and asexual stages), specifying the individual counts and presenting the total parasitic count.

7. Consider Disease Severity and Special Cases

Report schizonts separately, as they may indicate disease severity.

Count Plasmodium falciparum gametocytes individually, but include them in the total parasitic count.

For Plasmodium malariae or Plasmodium vivax, do not provide a gametocyte count due to challenges in differentiation from asexual parasites.

8. Clear Language and Avoiding Ambiguity:

Instead of stating “Negative,” report “No malaria parasites seen” to eliminate ambiguity.

Avoid using the “plus +” system, as it may provide an inaccurate estimate of malaria parasites.

Mastering the art of reporting blood smear for MPS results requires meticulous attention to detail, adherence to guidelines, and precision. By following these steps, healthcare professionals can contribute reliable data for intervention programs and ensure effective management of malaria-infected patients. Accurate reporting is not just a task; it’s a cornerstone in the global combat effort to combat malaria.

Reference: WHO SOP: MM-SOP-06b-eng

Limitations and Challenges

While BS for MPS stands as a stalwart in malaria diagnosis, it has its limitations and challenges. Understanding these nuances is essential for healthcare professionals to navigate the complexities of interpretation and ensure a holistic approach to patient care.

1. Laboratory Technician Dependency:

One prominent challenge in BS for MPS lies in its technician-dependent nature. The quality of the blood smear, the accuracy of staining, and the proficiency of microscopic examination are all contingent on the skills and experience of the laboratory technician or pathologist. Variances in technique and interpretation among operators can introduce potential inconsistencies in results, emphasizing the importance of ongoing training and quality assurance measures.

2. Variability in Parasite Density:

The accuracy of parasite density estimation, a crucial parameter in assessing infection severity, can be influenced by various factors. Variability in the distribution of parasites within the blood sample and potential discrepancies in the quantification process may contribute to uncertainties in parasite density measurements. This variability underscores the need for a cautious interpretation of results, with an acknowledgment of the potential limitations in quantitative assessments.

3. False Negatives and Positives:

While highly reliable, BS for MPS is not immune to false negatives and positives. False negatives may arise during the early stages of infection when parasite densities are low or due to intermittent parasite circulation in the bloodstream. Factors like improper staining, inadequate sample preparation, or human error during microscopic examination can also contribute to false negatives.

Conversely, false positives may occur if artifacts or normal cellular structures are overinterpreted as malaria parasites. Rigorous quality control measures and ongoing training are essential to mitigate the risk of false results, ensuring that diagnostic accuracy remains at the forefront of malaria management.

4. Resource and Infrastructure Constraints:

In resource-limited settings, where the burden of malaria is often highest, challenges related to equipment, reagent quality, and skilled personnel may pose additional hurdles. Access to reliable electricity, appropriate laboratory infrastructure, and a consistent supply chain for reagents can impact the consistent performance of the Blood Smear for MPS. Efforts to address these challenges are integral to improving the accessibility and reliability of malaria diagnostics in underserved regions.

Acknowledging these limitations and challenges is crucial for healthcare professionals and researchers alike. As technology advances and new diagnostic methods emerge, there is an ongoing commitment to refining and expanding the diagnostic toolkit to overcome these challenges and enhance the precision and accessibility of malaria diagnosis globally.

Conclusion

BS for MPS is a time-tested sentinel of hope in the ongoing battle against malaria. From the careful preparation of blood smears to the keen scrutiny of trained laboratory professionals, this diagnostic journey unfolds with a singular purpose—to unravel the microscopic secrets of Plasmodium parasites. As we traverse the nuances of staining techniques, microscopic examinations, and result interpretations, it becomes evident that the Blood Smear for MPS is not merely a test but a narrative, painting a vivid picture of the unseen world within.

While challenges such as operator dependency and variability persist, the landscape transforms with emerging technologies and continuous research, promising a future where accuracy, accessibility, and adaptability converge. In this quest for excellence, the commitment to refining diagnostic methodologies remains unwavering—a commitment fueled by the shared vision of a world where malaria’s impact is mitigated through the precision and dedication encapsulated within the microscopic tapestry of malaria diagnosis.